Suppr超能文献

超低分子量肝素对抗原诱导的气道高反应性的抑制作用。

Inhibition of antigen-induced airway hyperresponsiveness by ultralow molecular-weight heparin.

作者信息

Molinari J F, Campo C, Shakir S, Ahmed T

机构信息

Division of Pulmonary Diseases, University of Miami School of Medicine, Mount Sinai Medical Center, Miami Beach, Florida 33140, USA.

出版信息

Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):887-93. doi: 10.1164/ajrccm.157.3.9708027.

Abstract

Unfractionated heparin (UF-heparin) has been shown to prevent antigen-induced airway hyperresponsiveness (AHR), but it is ineffective when administered after the antigen challenge. We hypothesized that the failure of UF-heparin to modify postantigen AHR might depend on molecular weight. We therefore studied the effects of UF-heparin and three low-molecular-weight heparin fractions (medium-molecular-weight heparin [MMWH]; low-molecular-weight heparin [LMWH]; and ultralow-molecular-weight heparin [ULMWH]) on antigen-induced AHR and histamine release in bronchoalveolar lavage fluid (BALF). Specific lung resistance (SRL) was measured in 20 allergic sheep before, immediately after, and up to 2 h after challenge with Ascaris suum antigen. Airway responsiveness was expressed as the cumulative provocative dose of carbachol, in breath units, that increased SRL by 400% (PD400). PD400 was determined before and 2 h after antigen, both without and after treatment with aerosolized UF-heparin (1,000 U/kg) and various heparin fractions (0.04 mg/kg to 5 mg/kg) administered after the antigen challenge. Inhaled UF-heparin (n = 4), MMWH (n = 4), and LMWH (n = 6) failed to modify postantigen AHR when administered after the challenge. Only ULMWH (n = 6) inhibited postantigen AHR in a dose-dependent manner (percent protection ranged from 31% to 139%). In eight additional sheep, histamine in BALF was measured with a radioimmunoassay (RIA) before and after the segmental antigen challenge, without and after pretreatment with inhaled UF-heparin, LMWH, or ULMWH. Inhaled UF-heparin and LMWH inhibited antigen-induced histamine release as measured in BALF by 81% and 75%, respectively; whereas ULMWH was ineffective in this respect. We conclude that: (1) modification of antigen-induced AHR by fractionated heparins is molecular-weight dependent; and (2) only ULMWH attenuates AHR when administered after antigen challenge, via an unknown mast-cell-independent action.

摘要

普通肝素(UF - 肝素)已被证明可预防抗原诱导的气道高反应性(AHR),但在抗原激发后给药则无效。我们推测UF - 肝素不能改变抗原激发后的AHR可能取决于分子量。因此,我们研究了UF - 肝素和三种低分子量肝素组分(中分子量肝素[MMWH];低分子量肝素[LMWH];和超低分子量肝素[ULMWH])对支气管肺泡灌洗液(BALF)中抗原诱导的AHR和组胺释放的影响。在20只变应性绵羊中,在感染猪蛔虫抗原之前、之后立即以及之后长达2小时测量特异性肺阻力(SRL)。气道反应性以卡巴胆碱的累积激发剂量表示,以呼吸单位计,该剂量使SRL增加400%(PD400)。在抗原激发前后以及用雾化UF - 肝素(1000 U/kg)和各种肝素组分(0.04 mg/kg至5 mg/kg)在抗原激发后给药治疗后,测定PD400。吸入UF - 肝素(n = 4)、MMWH(n = 4)和LMWH(n = 6)在激发后给药时未能改变抗原激发后的AHR。只有ULMWH(n = 6)以剂量依赖性方式抑制抗原激发后的AHR(保护百分比范围为31%至139%)。在另外8只绵羊中,在节段性抗原激发前后,用放射免疫测定法(RIA)测量BALF中的组胺,在吸入UF - 肝素、LMWH或ULMWH预处理前后进行测量。吸入UF - 肝素和LMWH分别使BALF中测量的抗原诱导的组胺释放抑制81%和75%;而ULMWH在这方面无效。我们得出结论:(1)分级肝素对抗原诱导的AHR的改变取决于分子量;(2)只有ULMWH在抗原激发后给药时通过未知的非肥大细胞依赖性作用减弱AHR。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验